Mettler-Toledo International vs ResMed

Mettler-Toledo International (MTD), health care, and ResMed (RMD), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Mettler-Toledo International and ResMed are valued at about the same: $34.1B and $33.5B. Mettler-Toledo International trades at 37.2 times earnings and ResMed at 21.7. Over the past year Mettler-Toledo International's share price has moved +23.7% and ResMed's -3.26%.

Key facts

Mettler-Toledo International market value
$34.1B
ResMed market value
$33.5B
Mettler-Toledo International P/E
37.2
ResMed P/E
21.7
Mettler-Toledo International revenue
$4BFY to 2025-12-31
ResMed revenue
$5.7BFY to 2026-06-30
Superinvestors holding both
0

Market values as of .

Mettler-Toledo International vs ResMed: every measure side by side
Measure Mettler-Toledo International ResMed
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312026-06-30
Size
Market cap$34.1Bhigher$33.5Blower
Revenue$4Blower$5.7Bhigher
Earnings$869.2Mlower$1.5Bhigher
Employees16,600higher11,370lower
Total assets$3.7Blower$9Bhigher
Valuation
P/E37.2higher21.7lower
P/S8.5higher5.9lower
P/B439higher5.6lower
Dividend yield0.00%lower1.03%higher
Profitability
Operating margin—33.4%
Balance sheet
Net assets-$23.6Mlower$6.6Bhigher
Total liabilities$3.7Bhigher$2.4Blower
Total debt$2.2Bhigher$659.4Mlower
Cash on hand$66.9Mlower$1.5Bhigher
Price change
Today-0.83%lower-0.14%higher
1 year+23.7%higher-3.26%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Mettler-Toledo International only (3)

ResMed only (1)

Percentages are each holding's share of that investor's reported portfolio. Who owns MTD · Who owns RMD

Further comparisons

Learn

Questions and answers

Which is bigger, Mettler-Toledo International or ResMed?

By market value, Mettler-Toledo International is the larger: $34.1B against $33.5B for ResMed. By revenue in its latest fiscal year, ResMed is the larger: $5.7B against $4B for Mettler-Toledo International.

Which has the higher P/E ratio?

Mettler-Toledo International: 37.2, against 21.7 for ResMed. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher dividend yield?

ResMed: 1.03%, against 0.00% for Mettler-Toledo International. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Mettler-Toledo International: $2.2B, against $659.4M for ResMed. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Mettler-Toledo International and ResMed?

None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Mettler-Toledo International and 1 holds ResMed.

Cite this page

Funkfolio, “Mettler-Toledo International vs ResMed”, data as of 18 November 2026. https://funkfolio.com/compare/mtd-vs-rmd

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.